Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review

Published:2024-08 Issue:8 Volume:27 Page:1149-1173
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Thavorn Kednapa,Thompson Emily Rose,Kumar Srishti,Heiskanen Aliisa,Agarwal Anubhav,Atkins Harold,Shorr Risa,Hawrysh Terry,Chan Kelvin Kar-Wing,Presseau Justin,Ollendorf Daniel A.,Graham Ian D.,Grimshaw Jeremy M.,Lalu Manoj Mathew,Nochaiwong Surapon,Fergusson Dean A.,Hutton Brian,Coyle Doug,Kekre Natasha

Publisher

Elsevier BV

Reference84 articles.

1. Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia;Grover;Blood Adv,2022

2. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia;Park;N Engl J Med,2018

3. High cost of chimeric antigen receptor T-cells: challenges and solutions;Cliff;Am Clin Oncol Educ Book,2023

4. Cost-effectiveness analysis of tisagenlecleucel in the treatment of relapsed or refractory B-cell acute lymphoblastic leukaemia in children and young adults in Spain;Ribera Santasusana;Clinicoecon Outcomes Res,2020

5. Cost-effectiveness of chimeric antigen receptor T-cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia;Sarkar;J Natl Cancer Inst,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T Therapy can be a Useful Treatment Modality for more than Just Hematologic Malignancies;Internal Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP